메뉴 건너뛰기




Volumn 8, Issue 4 SUPPL., 2002, Pages

STI571 (Gleevec™) as a paradigm for cancer therapy

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; HYBRID PROTEIN; IMATINIB; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; PIPERAZINE DERIVATIVE; PROTEIN TYROSINE KINASE; PYRIMIDINE DERIVATIVE;

EID: 0036216405     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(02)02305-5     Document Type: Review
Times cited : (267)

References (37)
  • 5
    • 0015694748 scopus 로고
    • A new consistent abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and giemsa staining
    • (1973) Nature , vol.243 , pp. 290-293
    • Rowley, J.D.1
  • 6
    • 0029995607 scopus 로고    scopus 로고
    • The molecular biology of chronic myeloid leukemia
    • (1996) Leukemic , vol.10 , pp. 751-756
    • Melo, J.V.1
  • 9
    • 0034670036 scopus 로고    scopus 로고
    • The molecular biology of chronic myeloid leukemia
    • (2000) Blood , vol.96 , pp. 3343-3356
    • Deininger, M.W.1
  • 10
    • 0025117392 scopus 로고
    • Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome
    • (1990) Science , vol.247 , Issue.4944 , pp. 824-830
    • Daley, G.Q.1
  • 14
    • 0029947186 scopus 로고    scopus 로고
    • Effects of a selective inhibitor of the ABL tyrosine kinase on the growth of BCR-ABL positive cells
    • (1996) Nature Med. , vol.2 , pp. 561-566
    • Druker, B.J.1
  • 15
    • 0030853063 scopus 로고    scopus 로고
    • The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells
    • (1997) Blood , vol.90 , pp. 3691-3698
    • Deininger, M.W.1
  • 18
    • 0035810147 scopus 로고    scopus 로고
    • Efficacy and safety of a specific inhibitor of the Bcr-Abl tyrosine kinase in chronic myeloid leukemia
    • (2001) New Engl. J. Med. , vol.344 , pp. 1031-1037
    • Druker, B.J.1
  • 19
    • 0035810142 scopus 로고    scopus 로고
    • Activity of a specific inhibitor of the Bcr-Abl tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome
    • (2001) New Engl. J. Med. , vol.344 , pp. 1038-1042
    • Druker, B.J.1
  • 20
    • 0001338423 scopus 로고    scopus 로고
    • Phase II study of STI571, a tyrosine kinase inhibitor, in patients with resistant or refractory Philadelphia chromosome positive chronic myeloid leukemia
    • (2000) Blood , vol.96
    • Kantarjian, H.1
  • 21
    • 0000869570 scopus 로고    scopus 로고
    • A Phase II study to determine the safety and anti-leukemic effects of STI571 in patients with Philadelphia chromosome positive chronic myeloid leukemia in myeloid blast crisis
    • (2000) Blood , vol.96
    • Sawyers, C.L.1
  • 22
    • 0001566710 scopus 로고    scopus 로고
    • A Phase II study of STIS71 in adult patients with Philadelphia chromosome positive chronic myeloid leukemia in accelerated phase
    • (2000) Blood , vol.96
    • Talpaz, M.1
  • 23
    • 0035800507 scopus 로고    scopus 로고
    • Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
    • (2001) Science , vol.293 , pp. 876-880
    • Gorre, M.E.1
  • 24
    • 0035929673 scopus 로고    scopus 로고
    • Roots of clinical resistance to STI-571 cancer therapy
    • (2001) Science , vol.293 , pp. 2163
    • Hochhaus, A.1
  • 25
    • 0035929652 scopus 로고    scopus 로고
    • Roots of clinical resistance to STI-571 cancer therapy
    • (2001) Science , vol.293 , pp. 2163
    • Barthe, C.1
  • 26
    • 15644363454 scopus 로고    scopus 로고
    • Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
    • (1998) Science , vol.279 , pp. 577-580
    • Hirota, S.1
  • 27
    • 0033883060 scopus 로고    scopus 로고
    • KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors
    • (2000) Am. J. Pathol. , vol.156 , pp. 791-795
    • Lux, M.L.1
  • 28
    • 0000244046 scopus 로고    scopus 로고
    • Evaluation of the safety and efficacy of an oral molecularly-targeted therapy, STI571, in patients with unresectable or metastatic gastrointestinal stromal tumors (GISTS) expressing c-KIT (CD117)
    • (2001) Proc. Am. Soc. Clin. Oncol. , vol.20
    • Blanke, C.D.1
  • 30
    • 0033883653 scopus 로고    scopus 로고
    • The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth
    • (2000) Clin. Cancer Res. , vol.6 , pp. 3319-3326
    • Krystal, G.W.1
  • 31
    • 0034691761 scopus 로고    scopus 로고
    • Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI571
    • (2000) Oncogene , vol.19 , pp. 3521-3528
    • Wang, W.L.1
  • 32
    • 85112384821 scopus 로고    scopus 로고
    • STI571 inhibits the kinase activity of wild type and juxtamembrane c-kit mutants but not the exon 17 D816V mutation associated with mastocytosis
    • (2000) Blood , vol.96
    • Heinrich, M.C.1
  • 33
    • 0028224348 scopus 로고
    • Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5; 12) chromosomal translocation
    • (1994) Cell , vol.77 , pp. 307-316
    • Golub, T.R.1
  • 34
    • 0031454003 scopus 로고    scopus 로고
    • CGP57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL and TEL-PDGFR fusion proteins
    • (1997) Blood , vol.90 , pp. 4947-4952
    • Carroll, M.1
  • 35
    • 0003286050 scopus 로고    scopus 로고
    • Chronic myeloproliferative diseases with t(5; 12) and a PDGFRB fusion gene: Complete cytogenetic remissions on STI571
    • (2001) Blood , vol.98
    • Apperley, J.F.1
  • 36
    • 0034665138 scopus 로고    scopus 로고
    • Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class
    • (2000) Cancer Res. , vol.60 , pp. 5143-5150
    • Kilic, T.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.